Tag: Biotechnology
Analyst Ratings Update: Adaptimmune Therapeutics (NASDAQ: ADAP)
Adaptimmune Therapeutics, a clinical-stage biopharmaceutical company, has recently garnered the attention of analysts, with a mix of bullish and bearish sentiments. In the past...